Cloud Banner

Press Release

ALLERGAN, Lumenis, Shanghai Fosun Pharmaceutical(Group Co., Ltd., Syneron Medical Ltd, BTL and others are dominating the market for Switzerland medical aesthetic market in 2018


ALLERGAN founded in 2013 and headquartered in Dublin, Ireland, Allergan is engaged in developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan operates through seven business segments which include the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Medical aesthetics segment is the second largest market segment of Allergan. Botox, Juvederm, Latisse, Avage, Kybella, and Vaniqa are the aesthetics related products offered by Allergan.

Access Full Report at

The company operates in more than 100 countries across North America, Europe, Middle East, Africa, Asia, and rest of the world. Zeltiq Aesthetics, LifeCell, Aptalis, Nicrobrand, Oculeve, Inc. and others are some of its subsidiaries.

  • In April 2017, Allergan acquired ZELTIQ Aesthetics, Inc. (U.S.). This acquisition has benefitted Allergan to be sales leader in body contouring segment of medical aesthetics.


Lumenis is founded in January 1991, and headquartered in Yokeneam, Israel, Lumenis is the world’s largest energy-based medical device company for developing surgical, aesthetics, and ophthalmic applications.

The aesthetics segments offers treatment for ablative skin resurfacing, acne scars treatment, blepharoplasty, laser hair removal, pigmentation, rosacea, scar revision, skin toning, tattoo removal, vascular leg vein, non ablative skin resurfacing, photorejuvenation, and women's health. Technology used for production of such devices are- Ablative Lasers CO2, IPL - Intense Pulsed Light, Long Pulsed – Nd:YAG, and Diode Lasers as Non Ablative Laser.

It spans operations from North America, Europe, Asia Pacific, China and other countries.

  • In November 2015, Lumenis announced the acquisition of Pollogen Ltd. This acquisition will help Lumenis to capture more market segments in medical aesthetics.

Shanghai Fosun Pharmaceutical(Group)Co., Ltd.:

Shanghai Fosun Pharmaceutical(Group)Co., Ltd. Founded in 1980 with its headquarters at Israel, Alma Lasers is a global innovator and its business is segmented on the basis of laser, light-based, radio-frequency and ultrasound solutions for the aesthetics and surgical markets.

The surgical segment includes vaginal dryness & recurrent infections, vaginal tightening, post-menopause – GSM, stress urinary incontinence (SUI), ENT, liposuction, skin tightening, fat grafting, varicose veins and hyperhidrosis. The aesthetics segment includes hair removal, skin remodeling, scars & acne scars, acne, hyperhidrosis, psoriasis, vitiligo, trans epidermal delivery, body contouring, face contouring, cellulite, stretch marks, vascular lesions, pigmented lesions, tattoo removal, nail fungus and skin resurfacing.

The company's operations span across Europe, North America, Asia Pacific and South America.

  • In March 2016, Alma Lasers announced the launch of Accent Prime for the treatment of body contouring and skin tightening.

Client Testimonials